Eric Lefkofsky Hopes To Use Big Data to Improve Cancer Medication

Chronic diseases such as Alzheimer’s and cancer have been a major challenge in healthcare systems for many years. The capacity to use and implement big data, machine learning as well as artificial intelligence (AI) to understand the genetics algorithm patterns of a disease can enable the provision of better personalized as well as precise care and cure.

Eric Lefkofsky cofounded Tempus Labs to address the computational problem in 2015. The tech firm is based in Chicago and aims use big data not only to merge, consolidate, and clean the data but also digitize the information of each cancer patient. The digitized health information will assist physicians in treating future cancer patients. They will also learn from the data. Tempus has developed data pipelines whose main function is to collect and analyze clinical data of patients which will enable medical precision in future treatments.

Tempus Labs hopes keep cancer patient’s clinical as well as molecular data in a single sphere and available physicians. Cancer doctors would access the data and use it to make data-driven decisions in real -time. Data integration will allow doctors to learn from hundreds of patients diagnosed with cancer every year. The physicians will be able to get information on how patients respond to certain medications and learn how others were treated and use the information to improve future treatments.

To achieve its objective, Tempus has entered into partnerships with major healthcare organizations as well as academic institutions. It also collaborates with almost all National Cancer Institutes and Comprehensive Cancer Centers. The oncologists in the institutions send patients’ genomic sequencing at Tempus. In turn, Tempus, collect data and pairs molecular information before generating a report on the patient. It then sends a report to the institution and also allows them access to Tempus Labs’ operating system. Alzheimer’s disease could also benefit from use of big data. Researchers and government hope to use biological markers especially brain changes to help improve diagnosis as well as treatment of the disease.

About Eric Lefkofsky

Eric Lefkofsky is the co-founder of Tempus Labs. He is also involved in other businesses such as LightBank, Uptake Technologies, Mediaocean, and Echo Global Logistics among others. Together with his wife, Eric contributes generously to cancer research using Lefkofsky Family Foundation.

Eric acts an adjunct professor at the University of Chicago. He is a graduate of the University of Michigan. Eric Lefkofsky obtained Juris Doctorate from the University of Michigan Law School.